Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin‐A (hypocretin‐1)
Coleman B. Calva, Habiba Fayyaz, Jim R. Fadel
Journal of Neurochemistry (2017) Vol. 145, Iss. 3, pp. 232-244
Open Access | Times Cited: 21

Showing 21 citing articles:

Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems
Gary B. Kaplan, Gabrielle A. Lakis, Hryhoriy Zhoba
Brain Research Bulletin (2022) Vol. 186, pp. 106-122
Closed Access | Times Cited: 32
Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure
Marlene A. Wilson, Israel Liberzon, Merry L. Lindsey, et al.
Stress (2019) Vol. 22, Iss. 5, pp. 530-547
Open Access | Times Cited: 36
Reviewing the role of the orexinergic system and stressors in modulating mood and reward-related behaviors
Salar Vaseghi, Shahram Zarrabian, Abbas Haghparast
Neuroscience & Biobehavioral Reviews (2021) Vol. 133, pp. 104516-104516
Closed Access | Times Cited: 23
Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction
Coleman B. Calva, Jim R. Fadel
Brain Research (2018) Vol. 1731, pp. 145921-145921
Open Access | Times Cited: 28
Cholinergic neurotransmission in the basolateral amygdala during cued fear extinction
Devin M. Kellis, Kris F. Kaigler, Eric Witherspoon, et al.
Neurobiology of Stress (2020) Vol. 13, pp. 100279-100279
Open Access | Times Cited: 27
Intranasal insulin and orexins to treat age-related cognitive decline
Jennifer M. Erichsen, Coleman B. Calva, Lawrence P. Reagan, et al.
Physiology & Behavior (2021) Vol. 234, pp. 113370-113370
Open Access | Times Cited: 22
The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target
Fan Gao, Tao Liu, Miao Tuo, et al.
Neuroscience Letters (2021) Vol. 765, pp. 136247-136247
Closed Access | Times Cited: 22
Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson’s Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity
Miloš Stanojlović, Jean Pierre Pallais Yllescas, Aarthi Vijayakumar, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 12, pp. 8435-8450
Open Access | Times Cited: 25
Introduction to the Special Issue: “Making orexin-based therapies for addiction a reality: What are the steps from here?”
Morgan H. James, Gary Aston‐Jones
Brain Research (2020) Vol. 1731, pp. 146665-146665
Open Access | Times Cited: 22
Effects of Intranasal Orexin-A (Hypocretin-1) Administration on Neuronal Activation, Neurochemistry, and Attention in Aged Rats
Coleman B. Calva, Habiba Fayyaz, Jim R. Fadel
Frontiers in Aging Neuroscience (2020) Vol. 11
Open Access | Times Cited: 21
Higher orexin-A levels are associated with treatment response to clozapine in patients with schizophrenia: A cross-sectional study
Po‐Yu Chen, Chih‐Chiang Chiu, Chin‐Kuo Chang, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 258-267
Closed Access | Times Cited: 2
Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson’s disease patients
Shen Huang, Zhenxiang Zhao, Jianjun Ma, et al.
Neuroscience Letters (2020) Vol. 741, pp. 135480-135480
Closed Access | Times Cited: 16
Hypocretin (Orexin) Replacement Therapies
Erica Seigneur, Luı́s de Lecea
Medicine in Drug Discovery (2020) Vol. 8, pp. 100070-100070
Open Access | Times Cited: 12
Pyridostigmine bromide elicits progressive and chronic impairments in the cholinergic anti-inflammatory pathway in the prefrontal cortex and hippocampus of male rats
H.E. Burzynski, Victoria A. Macht, J.L. Woodruff, et al.
Neurobiology of Stress (2022) Vol. 18, pp. 100446-100446
Open Access | Times Cited: 7
Delayed cognitive impairments in a rat model of Gulf War Illness are stimulus-dependent
H.E. Burzynski, Kathy Ayala, M.A. Frick, et al.
Brain Behavior and Immunity (2023) Vol. 113, pp. 248-258
Open Access | Times Cited: 3
Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists
Jason W. Skudlarek, Christina N. DiMarco, Kerim Babaoglu, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 6, pp. 1364-1370
Closed Access | Times Cited: 8
Orexin (hypocretin) mediates light‐dependent fluctuation of hippocampal function in a diurnal rodent
Joel E. Soler, Hang Xiong, Faiez Samad, et al.
Hippocampus (2021) Vol. 31, Iss. 10, pp. 1104-1114
Open Access | Times Cited: 6
The wake- and sleep-modulating neurons of the lateral hypothalamic area demonstrate a differential pattern of degeneration in Alzheimer’s disease
Abhijit Satpati, Felipe Luiz Pereira, Alexander Soloviev, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Impaired Vigilance in Patients with Narcolepsy Type 1: A Psychomotor Vigilance Task Study
Jiaqin Yu, Yuyan Zhou, Xiao Han, et al.
Nature and Science of Sleep (2024) Vol. Volume 16, pp. 2021-2028
Open Access
Orexins and Cognition: Neuroanatomical and Neurochemical Substrates
Joshua A. Burk, Eden B. Maness, Sarah A. Blumenthal, et al.
Elsevier eBooks (2019), pp. 139-153
Closed Access | Times Cited: 3
Alzheimer’s Disease, Early Diagnosis
Giovanni Andrisani, Giorgia Andrisani
Advances in Alzheimer s Disease (2020) Vol. 09, Iss. 03, pp. 33-46
Open Access
Page 1

Scroll to top